Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clinistretch Short bandage 6cm x 5m
20020201181
|
Clinistretch Short bandage 6cm x 5m | Arm Sling/Bandages | Dressings | No data available |
|
CliniSure silicone sheath pop on 40mm
22306153036
|
CliniSure silicone sheath pop on 40mm | Incontinence Sheaths | Incontinence Appliances | No data available |
|
Clinitar 1% cream
1305020C0BIAABJ
|
Clinitar (Topical) | Tars | Skin | No data available |
|
Clinitar 2% shampoo
1309000C0BFAAAN
|
Clinitar (Scalp) | Coal tar | Skin | No data available |
|
Clinitest testing tablets
0601060U0BFAAAB
|
Clinitest (Reagent) | Urine testing reagents | Endocrine System | No data available |
|
ClinOptic HA 0.4% eye drops preservative free
21300000988
|
ClinOptic HA 0.4% eye drops preservative free | Eye Products | Appliances | No data available |
|
Clinoril 100mg tablets
1001010S0BBAAAA
|
Clinoril | Sulindac | Musculoskeletal and Joint Diseases | No data available |
|
Clinoril 200mg tablets
1001010S0BBABAB
|
Clinoril | Sulindac | Musculoskeletal and Joint Diseases | No data available |
|
Clintec glucose 20% infusion 500ml bags
0902021G0BDAABB
|
Clintec glucose | Glucose | Nutrition and Blood | No data available |
|
Clintec glucose 50% infusion 500ml bags
0902021G0BDABAY
|
Clintec glucose | Glucose | Nutrition and Blood | No data available |
|
Clinutren 1.5 Fibre liquid plum
090402000BBNYA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren 1.5 Fibre liquid vanilla
090402000BBNXA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Dessert caramel
090402000BBJXA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Dessert chocolate
090402000BBJYA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Dessert peach
090402000BBJZA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Dessert vanilla
090402000BBKAA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Fruit liquid grapefruit
090402000BBKYA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren ISO liquid chocolate
090402000BBKBA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren ISO liquid strawberry & raspberry
090402000BBKDA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren ISO liquid vanilla
090402000BBKEA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Junior liquid
090402000BBMRA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Junior powder
090402000BBKMA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren Mix Plus Fibre
090402000BBMTA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Clinutren thickened drink liquid
191300000BMCMA0
|
Proprietary compound preparation BNF 1913000 | Other cordial/soft drink preparations | Other Drugs and Preparations | No data available |
|
Clioquinol 3% / Hydrocortisone 1% cream
1304000V0AACACA
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.